Inclisiran: Government’s strategy to promote cholesterol lowering drug after Brexit was spectacular failure | The BMJ

​  The government’s policy to fast track “innovative” drugs into the NHS to showcase the UK as a great place for industry has been described as “a pretty … Read More 

Share the news

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.